Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
verITI-8: rFVIIIFc for First-Time ITI in Hemophilia A
NCT03093480Phase 4Completed
- Sponsor
- Sanofi
- Start
- Dec 2017
- Primary completion
- May 2020
- Modality
- Fc-Fusion Proteins
- Countries
- 10
01
Overview
A Phase 4 trial of eftrenonacog alfa in hemophilia A, sponsored by Sanofi. Started Dec 2017; status: completed.
02
Drugs
eftrenonacog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT03093480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03093480.